Centro Nacional de Epidemiología-ko ikertzaileekin lankidetzan egindako argitalpenak (27)

2017

  1. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2869-2878

2016

  1. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions

    PLoS ONE, Vol. 9, Núm. 12

  2. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

  3. Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6

2013

  1. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: Role of antiretroviral therapy

    AIDS, Vol. 27, Núm. 2, pp. 181-189

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2011

  1. HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain

    Antiviral Therapy, Vol. 16, Núm. 4, pp. 585-589

2009

  1. Delayed diagnosis of HIV infection in a multicenter cohort: Prevalence, risk factors, response to HAART and impact of mortality

    Current HIV Research, Vol. 7, Núm. 2, pp. 224-230

  2. Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain project itinere group

    European Addiction Research, Vol. 15, Núm. 3, pp. 171-178

  3. The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies

    Vaccine, Vol. 27, Núm. 20, pp. 2674-2679

2008

  1. Hepatitis B vaccination: An unmet challenge in the era of harm reduction programs

    Journal of Substance Abuse Treatment, Vol. 34, Núm. 4, pp. 398-406

  2. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville

    European Addiction Research, Vol. 14, Núm. 3, pp. 116-124

2007

  1. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART

    AIDS, Vol. 21, Núm. 18, pp. 2521-2527

  2. Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): Metodología y primeros resultados

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 1, pp. 23-31

  3. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit"

    Journal of Clinical Virology, Vol. 38, Núm. 1, pp. 87-90

  4. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: Gender differences and other related factors

    Epidemiology and Infection, Vol. 135, Núm. 4, pp. 592-603

2006

  1. HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates

    Journal of Clinical Virology, Vol. 35, Núm. 3, pp. 244-249